​

Funding Round

Series B - GRO Biosciences

Series B - GRO Biosciences

Investment Firm

Overview

GRO Biosciences is a biotechnology company that develops a protein therapeutics technology to improve treatments across multiple diseases.

Announced Date

Jul 19, 2024

Closed on Date

Jul 19, 2024

Funding Type

Series B

Highlights

N/A

Location

N/A

Social

N/A

Investor Lead

Atlas Venture

Atlas Venture

Atlas Venture is a early_stage_venture and late_stage_venture and post_ipo and seed and venture firm.

Access Biotechnology

Access Biotechnology

Access Biotechnology is a early_stage_venture and late_stage_venture and post_ipo and seed and venture firm.

Participant Investors

6

Investor Name
Participant InvestorRedmile Group
Participant InvestorAccess Biotechnology
Participant InvestorInnovation Endeavors
Participant InvestorDigitalis Ventures
Participant InvestorAtlas Venture

Round Details and Background

GRO Biosciences raised $60300000 on 2024-07-19 in Series B

GRO Biosciences is a biotechnology company that develops a protein therapeutics technology to improve treatments across multiple diseases.

Company Funding History

7

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Sep 14, 2020
Grant - GRO Biosciences
1-1.2M
Jan 29, 2019
Grant - GRO Biosciences
1-225.0K
Jul 19, 2024
Series B - GRO Biosciences
6-60.3M
Feb 08, 2018
Seed Round - GRO Biosciences
7-2.4M

Recent Activity

There is no recent news or activity for this profile.